Knownwell
Provides weight-inclusive metabolic health and primary care through virtual and in-person clinics.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Weight-inclusive clinical care
- Product type
- Service
- Stage
- Series A
- Headquarters
- Boston, USA
- Region
- North America
- Founded
- 2022
- Total funding
- $25M
What they do
knownwell provides hybrid obesity care, combining medical, nutrition and behavioral care in clinics and virtually. In January 2026 it became a recognized NovoCare provider as Novo Nordisk launched the Wegovy pill. Its $25 million financing in October 2025, led by CVS Health Ventures, brought total funding above $50 million.
Leadership & founders
Leadership as of 14 November 2026.
- Brooke Boyarsky Pratt
Chief Executive Officer & Co-Founder
- Angela Fitch
Founder
Investors
- Andreessen Horowitz
- Spark Capital
- Manatt Venture Fund
- CVS Health Ventures
History and progression
How Knownwell got here, step by step.
20 October 2025
$25 million financing
Raised $25 million led by CVS Health Ventures, bringing total funding above $50 million.
5 January 2026
NovoCare provider
Became a recognized NovoCare provider as Novo Nordisk launched the Wegovy pill.
Key products
- Hybrid obesity care
- Obesity medicine combining medical, nutrition and behavioral care in clinics and virtually
Recent news
5 January 2026
Novo Nordisk launches Wegovy pill with knownwell as a NovoCare provider20 October 2025
knownwell raises $25 million
Related companies
Your daily HealthTech Signal
No hype. Just signal.
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: